Praxis Precision Medicines to Present at Two February Investor Conferences#Praxis #Precision #Medicines #Present #February #Investor #Conferences
Tag: Precision
Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities By Investing.com
Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four…
Precision Biosciences director Melinda Brown acquires $13,722 in stock By Investing.com
Melinda Brown, a director at Precision BioSciences Inc . (NASDAQ:), recently increased her stake in the…